Impaired self-renewal and differentiation of RapGEF2−/− hematopoietic progenitors in vitro. The number of BFU-E, CFU-Mix, and CFU-GM colonies formed from RapGEF2+/+ and RapGEF2−/− E10.5 yolk sac cells (A-C) or embryonic cells (D-F). The average and standard deviation were derived from 3 independent colony-formation assays. (G-H) Representative photographs showing the size of the CFU-GM colonies derived from RapGEF2+/+ (G) and RapGEF2−/− (H) E10.5 yolk sac cells. (I-J) Histograms showing the number of colonies formed in the initial plating 0′ and the subsequent replating i to iii of E10.5 yolk sac (I) or embryonic (J) cells. The average, standard deviation, and statistical significance were derived from 3 independent assays. *P < .05, **P < .005, ***P < .0005. (K-L) Flow cytometry images showing the distribution of CD71+Ter119+ (K) and Gr1+/Mac1+ (L) cell populations. (M-N) Bar graphs displaying the number of BFU-E, CFU-GM, and CFU-Mix colonies formed after plating FACS-sorted c-Kit+/CD34+ double-positive HPCs from E10.5 yolk sac (M) or embryonic cells (N). Compared with RapGEF2+/+, 5 times more number of RapGEF2−/− yolk sacs and embryos were pooled to obtain sufficient number of c-Kit+/CD34+ HPCs.